Navigation Links
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Date:10/5/2007

INDIANAPOLIS, Oct. 5 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today that as a part of on-going discussions with the U.S. Food and Drug Administration (FDA), the company has updated the Zyprexa(R) (olanzapine) and Symbyax(R) (olanzapine and fluoxetine HCl) U.S. product labels. This new labeling information is available at http://www.Zyprexa.com and http://www.Symbyax.com.

The updates reflect recently completed pooled analyses of Lilly's clinical trial data in adults and adolescents(1), information from two large non-Lilly studies of atypical antipsychotics (CATIE and CAFE) and discussions with the FDA. Specifically, the changes include new warnings for weight gain and hyperlipidemia (elevation of triglycerides and cholesterol) and updated information in the warning for hyperglycemia (elevated blood sugar), including additional language on a greater association of increases in glucose levels with olanzapine than with some other atypical antipsychotics. Lilly continues to work with the FDA and will provide additional data and analyses as they become available.

"Today's communication is part of Lilly's historical and ongoing commitment to inform doctors and patients about updated prescribing information," said Sara Corya, M.D., global medical director, Lilly. "Zyprexa is an important treatment option for patients suffering from the devastating effects of schizophrenia and bipolar disorder, as is Symbyax for patients with bipolar depression. This information will continue to help healthcare professionals evaluate and make the best treatment decisions for individual patients," she added.

Information on the potential risks of weight gain and elevations in blood sugar and lipids already exists in the Zyprexa and Symbyax labels. These meta- bolic changes and weight gain have been reported as adverse events since Zyprexa's approval in
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
3. Eli Lilly Releases Digital Insulin Pen
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...n bonds in the body's blood vessels significantly ..., according to a study conducted by National Insti...ding suggests the medication could be a new treatm...ertain complications of diabetes. The drug, ALT-71...
...ways been hampered by high rates of relapse, even ...om the Drug Abuse Program of the VU Medical Center...s of the National Institute on Drug Abuse (NIDA) h...ad to a new generation of medications to prevent r...
...gnosed and treated in many cases, say US doctors. ...n the legs and arms become blocked with the same k...ary artery disease. The best way of treating it is...kes walking painful, regular exercise does actuall...
...ring adulthood may protect against premenopausal b...n investigators have found that childhood milk con... cancer before the menopause.Dr Annette Hjartaker ...studied 48,844 premenopausal Norwegian women. Part...
Other Medicine News:
(Date:10/6/2008)...ts Discuss Promising Research at The American Coll...l Meeting, WASHINGTON, Oct. 6 /- New...n and seniors was presented at The American Colleg..., "Practical Applications of,Probiotics in Health ...pediatrics, aging, and nutrition discussed the pot...
(Date:10/6/2008)...NTAIN VIEW, Calif. and SEATTLE, Oct. 6 /PRNewswire...rd-generation human genome sequencing,company, and...ounced their,partnership to conduct populationwide...ct, Complete Genomics will use its proprietary,DNA...om samples provided by,ISB. Then, once proof-of-co...
(Date:10/6/2008)... TARGIT Procedure May Eliminate 6 Weeks of Radiati...reatment over the Internet Wednesday, October 2...a.com/explorehealth , HAMPTON, Va., Oct. 6 /PRNew...when she was diagnosed with breast cancer in May. ...ast? How about radiation or chemotherapy?, , To ...
(Date:10/5/2008)...ults published in New England Journal of Medicine ...afety profile of SPIRIVA(R),HandiHaler(R), RIDGEF...Results of the,UPLIFT (Understanding Potential Lon... showed that SPIRIVA(R) HandiHaler(R) (tiotropium ... in lung function for up to 4,years as measured by...
Breaking Medicine Technology:'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6So Much to Do So Little Sleep 22463 1So Much to Do So Little Sleep 22463 2So Much to Do So Little Sleep 22463 3Get in Step With Summer Foot Care 22459 1Get in Step With Summer Foot Care 22459 2Get in Step With Summer Foot Care 22459 3The DataTrace 28R 29 RF System the Latest High Performance Radio Data Logger for Real Time Process Data Collection Reporting and Analysis Is Launc 22455 1The DataTrace 28R 29 RF System the Latest High Performance Radio Data Logger for Real Time Process Data Collection Reporting and Analysis Is Launc 22455 2Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles 22450 1Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles 22450 2
....5 and 40/25 mg/day and Amlodipine +,Benazepril 5/...of,Hypertension Twenty-Second Annual Scientific Me... -- New data,presented today at the American Socie...ic Meeting (ASH 2007) in Chicago,demonstrated that...n medoxomil/hydrochlorothiazide) was associated wi...
...07 - Results from phase III,clinical trials and fu... the 16th Congress of the European Academy of,Derm...hted the,efficacy and safety profile of alitretino...tients with severe refractory chronic,hand eczema....ere Chronic Hand,Eczema (CHE) refractory or unresp...
Other Medicine Technology:Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
...quality at low light intensity. Leica DFC300 F low...y designed for imaging applications where limited ...reate bright, vibrant images without noise or colo...he Leica cameras allow dark and light objects to b...
Coolpix 4500 microscope package includes Coolpix 4500 digital camera, MDC-A relay lens and EH52 AC adapter.
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi
Hema-G Stains for Geometric Data Hemastainer. Formulated to provide consistent performance. Stains are quality control tested on human blood smears to ensure proper staining and absence of precipitat
Medicine Products: